357 related articles for article (PubMed ID: 25073919)
21. Biological activities of quinoline derivatives.
Kumar S; Bawa S; Gupta H
Mini Rev Med Chem; 2009 Dec; 9(14):1648-54. PubMed ID: 20088783
[TBL] [Abstract][Full Text] [Related]
22. Identification of quinoline-chalcones and heterocyclic chalcone-appended quinolines as broad-spectrum pharmacological agents.
Atukuri D; S V; R S; L V; R P; M M R
Bioorg Chem; 2020 Dec; 105():104419. PubMed ID: 33142228
[TBL] [Abstract][Full Text] [Related]
23. Discovery of 1-benzoyl-3-cyanopyrrolo[1,2-a]quinolines as a new series of apoptosis inducers using a cell- and caspase-based high-throughput screening assay. 2: Structure-activity relationships of the 4-, 5-, 6-, 7- and 8-positions.
Kemnitzer W; Kuemmerle J; Jiang S; Sirisoma N; Kasibhatla S; Crogan-Grundy C; Tseng B; Drewe J; Cai SX
Bioorg Med Chem Lett; 2009 Jul; 19(13):3481-4. PubMed ID: 19467598
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and in vitro anticancer evaluation of some novel hexahydroquinoline derivatives having a benzenesulfonamide moiety.
Al-Said MS; Ghorab MM; Al-Dosari MS; Hamed MM
Eur J Med Chem; 2011 Jan; 46(1):201-7. PubMed ID: 21112675
[TBL] [Abstract][Full Text] [Related]
25. New water soluble pyrroloquinoline derivatives as new potential anticancer agents.
Ferlin MG; Marzano C; Dalla Via L; Chilin A; Zagotto G; Guiotto A; Moro S
Bioorg Med Chem; 2005 Aug; 13(15):4733-9. PubMed ID: 15936202
[TBL] [Abstract][Full Text] [Related]
26. In vitro anticancer screening and radiosensitizing evaluation of some new quinolines and pyrimido[4,5-b]quinolines bearing a sulfonamide moiety.
Ghorab MM; Ragab FA; Heiba HI; Arafa RK; El-Hossary EM
Eur J Med Chem; 2010 Sep; 45(9):3677-84. PubMed ID: 20684857
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis and anticancer evaluation of novel tetrahydroquinoline derivatives containing sulfonamide moiety.
Ghorab MM; Ragab FA; Hamed MM
Eur J Med Chem; 2009 Oct; 44(10):4211-7. PubMed ID: 19540022
[TBL] [Abstract][Full Text] [Related]
28. Styrylquinoline - A Versatile Scaffold in Medicinal Chemistry.
Musiol R
Med Chem; 2020; 16(2):141-154. PubMed ID: 31161997
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of 7-oxo-7H-naphtho[1,2,3-de]quinoline derivatives as potential anticancer agents active on multidrug resistant cell lines.
Dzieduszycka M; Bontemps-Gracz MM; Stefańska B; Martelli S; Piwkowska A; Arciemiuk M; Borowski E
Bioorg Med Chem; 2006 May; 14(9):2880-6. PubMed ID: 16458007
[TBL] [Abstract][Full Text] [Related]
30. Discovery of 2-[2-(5-nitrofuran-2-yl)vinyl]quinoline derivatives as a novel type of antimetastatic agents.
Tseng CH; Tzeng CC; Chiu CC; Hsu CY; Chou CK; Chen YL
Bioorg Med Chem; 2015 Jan; 23(1):141-8. PubMed ID: 25467291
[TBL] [Abstract][Full Text] [Related]
31. Recent Progress in the Development of Quinoline Derivatives for the Exploitation of Anti-Cancer Agents.
Man RJ; Jeelani N; Zhou C; Yang YS
Anticancer Agents Med Chem; 2021; 21(7):825-838. PubMed ID: 32416703
[TBL] [Abstract][Full Text] [Related]
32. Discovery of a new anilino-3H-pyrrolo[3,2-f]quinoline derivative as potential anti-cancer agent.
Via LD; Gia O; Gasparotto V; Ferlin MG
Eur J Med Chem; 2008 Feb; 43(2):429-34. PubMed ID: 17573162
[TBL] [Abstract][Full Text] [Related]
33. Discovery, synthesis and molecular substantiation of N-(benzo[d]thiazol-2-yl)-2-hydroxyquinoline-4-carboxamides as anticancer agents.
Bindu B; Vijayalakshmi S; Manikandan A
Bioorg Chem; 2019 Oct; 91():103171. PubMed ID: 31382059
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, molecular modeling and biological evaluation of 2-aminomethyl-5-(quinolin-2-yl)-1,3,4-oxadiazole-2(3H)-thione quinolone derivatives as novel anticancer agent.
Sun J; Zhu H; Yang ZM; Zhu HL
Eur J Med Chem; 2013 Feb; 60():23-8. PubMed ID: 23279864
[TBL] [Abstract][Full Text] [Related]
35. Tailored Quinolines Demonstrate Flexibility to Exert Antitumor Effects through Varied Mechanisms-A Medicinal Perspective.
Sharma S; Singh A; Sharma S; Sharma R; Singh J; Kinarivala N; Nepali K; Liou JP
Anticancer Agents Med Chem; 2021; 21(3):288-315. PubMed ID: 32900354
[TBL] [Abstract][Full Text] [Related]
36. Recent advances in research of natural and synthetic bioactive quinolines.
Chung PY; Bian ZX; Pun HY; Chan D; Chan AS; Chui CH; Tang JC; Lam KH
Future Med Chem; 2015; 7(7):947-67. PubMed ID: 26061110
[TBL] [Abstract][Full Text] [Related]
37. Quinoline anticancer agents active on DNA and DNA-interacting proteins: From classical to emerging therapeutic targets.
Lauria A; La Monica G; Bono A; Martorana A
Eur J Med Chem; 2021 Aug; 220():113555. PubMed ID: 34052677
[TBL] [Abstract][Full Text] [Related]
38. Unveiling novel 2-cyclopropyl-3-ethynyl-4-(4-fluorophenyl)quinolines as GPCR ligands via PI3-kinase/PAR-1 antagonism and platelet aggregation valuations; development of a new class of anticancer drugs with thrombolytic effects.
Thangarasu P; Thamarai Selvi S; Manikandan A
Bioorg Chem; 2018 Dec; 81():468-480. PubMed ID: 30243238
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and biological evaluation of new rhodanine analogues bearing 2-chloroquinoline and benzo[h]quinoline scaffolds as anticancer agents.
Ramesh V; Ananda Rao B; Sharma P; Swarna B; Thummuri D; Srinivas K; Naidu VG; Jayathirtha Rao V
Eur J Med Chem; 2014 Aug; 83():569-80. PubMed ID: 24996143
[TBL] [Abstract][Full Text] [Related]
40. Discovery of 4-anilinofuro[2,3-b]quinoline derivatives as selective and orally active compounds against non-small-cell lung cancers.
Chen YW; Chen YL; Tseng CH; Liang CC; Yang CN; Yao YC; Lu PJ; Tzeng CC
J Med Chem; 2011 Jul; 54(13):4446-61. PubMed ID: 21599000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
